PI Publications
- 2020Characterization of therapy-related acute leukemia in hereditary breast-ovarian carcinoma patients: role of BRCA1 mutation and topoisomerase II-directed therapy. Med Oncol. 37(5):48. PMID: 32277283
Bagal B, Kumar R, Gaur T, Talreja V, Bonda A, Patkar N, Shetty D, Kowtal P, Subramanian PG, Gupta S, Sarin R, Hasan SK
- 2018Singhal M, Sahoo TP, Aggarwal S, Singhvi A, Kaushal V, Rajpurohit S, Parthasarthi KM, Vora A, Ganvir M, Gupta S, Parikh PM.
Practical consensus recommendations on ovarian suppression in early breast cancer (adjuvant).South Asian J Cancer. 2018 Apr-Jun;7(2):151-155. doi: 10.4103/sajc.sajc_125_18.
Gupta S, Singh M, Vora A, Babu G, Walia M, Nautial V, Saha R, Smruti BK, Sharma JB, Koul R, Parikh PM, Aggarwal S.Practical consensus recommendations on duration of adjuvant hormonal therapy in breast cancer.South Asian J Cancer. 2018 Apr-Jun;7(2):142-145. doi: 10.4103/sajc.sajc_122_18.
Babu G, Goel A, Agarwal S, Gupta S, Kumar P, Smruti BK, Goel V, Sarangi R, Gairola M, Aggarwal S, Parikh PM.Practical consensus recommendations regarding the management of hormone receptor positive early breast cancer in elderly women.South Asian J Cancer. 2018 Apr-Jun;7(2):123-126. doi: 10.4103/sajc.sajc_117_18.
Bahl A, Singh R, Wadhwa J, Gupta S, Ahmed M, Uppal PN, Parikh PM, Aggarwal S.Practical consensus recommendations regarding the management of HER2 neu positive early breast cancer.South Asian J Cancer. 2018 Apr-Jun;7(2):102-105. doi: 10.4103/sajc.sajc_111_18.
Aggarwal S, Vaid A, Ramesh A, Parikh PM, Purohit S, Avasthi B, Gupta S, Ranjan S, Kaushal V, Salim S, Singh R, Minhas S, Doval D.Practical consensus recommendations on management of HR + ve early breast cancer with specific reference to genomic profiling.South Asian J Cancer. 2018 Apr-Jun;7(2):96-101. doi: 10.4103/sajc.sajc_110_18.
Wadasadawala T, Mondal M, Paul SN, Parmar V, Nair N, Shet T, Desai S, Gupta S, Sarin R.Should molecular subtype be recommended as one of the selection criteria for accelerated partial breast irradiation? Preliminary results from an Asian cohort. J Contemp Brachytherapy. 2018 Feb;10(1):47-57. doi: 10.5114/jcb.2018.74137. Epub 2018 Feb 28.
Bajpai J, Panda PK, Kagwade S, Govilkar M, Velaskar S, Kembhavi Y, Gupta S, Ghosh J, Deodhar JTranslation and validation of European Organization for Research and Treatment for Cancer quality of life questionnaire-OV-28 module into Indian languages (Hindi and Marathi) to study quality of life of ovarian cancer patients from a tertiary care cancer
Chatterjee S, Chaubal R, Maitra A, Gardi N, Dutt A, Gupta S, Badwe RA, Majumder PP, Pandey P.Pre-operative progesterone benefits operable breast cancer patients by modulating surgical stress.Breast Cancer Res Treat. 2018 Mar 21. doi: 10.1007/s10549-018-4749-3. [Epub ahead of print]
Gupta S, Maheshwari A, Parab P, Mahantshetty U, Hawaldar R, Sastri Chopra S, Kerkar R, Engineer R, Tongaonkar H, Ghosh J, Gulia S, Kumar N, Shylasree TS, Gawade R, Kembhavi Y, Gaikar M, Menon S, Thakur M, Shrivastava S, Badwe R.J ClinNeoadjuvant Chemotherapy Followed by Radical Surgery Versus Concomitant Chemotherapy and Radiotherapy in Patients With Stage IB2, IIA, or IIB Squamous Cervical Cancer: A Randomized Controlled Trial.Oncol. 2018 Feb 12:JCO2017759985. doi: 10.1200/JCO.2017.7
Shrivastava S, Mahantshetty U, Engineer R, Chopra S, Hawaldar R, Hande V, Kerkar RA, Maheshwari A, Shylasree TS, Ghosh J, Bajpai J, Gurram L, Gulia S, Gupta S;Cisplatin Chemoradiotherapy vs Radiotherapy in FIGO Stage IIIB Squamous Cell Carcinoma of the Uterine Cervix: A Randomized Clinical Trial.Gynecologic Disease Management Group.JAMA Oncol. 2018 Apr 1;4(4):506-513. doi: 10.1001/jamaoncol.2017.5179.
Pai T, Gupta S, Gurav M, Nag S, Shet T, Patil A, Desai S.Evidence for the association of Epstein-Barr Virus in breast cancer in Indian patients using in-situ hybridization technique.Breast J. 2018 Jan;24(1):16-22. doi: 10.1111/tbj.12828. Epub 2017 May 30.
Mahantshetty U, Teni T, Naga P, Hotwani C, Umesh S, Kannan S, Hande V, Pawar S, Engineer R, Chopra S, Deodhar K, Maheshwari A, Gurram L, Gupta S, Shrivastava SK.Impact of HPV 16/18 infection on clinical outcomes in locally advanced cervical cancers treated with radical radio (chemo) therapy - A prospective observational study.Gynecol Oncol. 2018 Feb;148(2):299-304. doi: 10.1016/j.ygyno.2017.11.034. Epub 2017 Dec
Noronha V, Joshi A, Patil VM, Banavali SD, Gupta S, Parikh PM, Marfatia S, Punatar S, More S, Goud S, Nakti D, Prabhash K.Phase III randomized trial comparing intravenous to oral iron in patients with cancer- related iron deficiency anemia not on erythropoiesis stimulating agents.Asia Pac J Clin Oncol. 2018 Apr;14(2):e129-e137. doi: 10.1111/ajco.12762. Epub 2017 Aug 28.
- 2017Joshi A, Patil VM, Noronha V, Ramaswamy A, Gupta S, Bhattacharjee A, Bonda A, Chandrakanth MV, Ostwal V, Khattry N, Banavali S, Prabhash K.
EMERALD: Emergency visit audit of patients treated under medical oncology in a tertiary cancer center: Logical steps to decrease the burden.South Asian J Cancer. 2017 Oct-Dec;6(4):186-189. doi: 10.4103/sajc.sajc_128_17
Maheshwari, A. & Gupta, S.Controversies in Gynaecologic Oncology.Indian J Gynecol Oncolog (2017) 15(Suppl 1): 1. https://doi.org/10.1007/s40944-017-0153-x
Agarwala V, Choudhary N, Gupta S.A Risk-benefit Assessment Approach to Selection of Adjuvant Chemotherapy in Elderly Patients with Early Breast Cancer: A Mini Review.Indian J Med Paediatr Oncol. 2017 Oct-Dec;38(4):526-534. doi: 10.4103/ijmpo.ijmpo_96_17. Review
Wadasadawala T, Lewis S, Parmar V, Budrukkar A, Gupta S, Nair N, Shet T, Badwe R, Sarin R.Bilateral Breast Cancer After Multimodality Treatment: A Report of Clinical Outcomes in an Asian Population.Clin Breast Cancer. 2017 Nov 9. pii:S1526-8209(17)30383-X. doi:10.1016/j.clbc.2017.11.003. [Epub ahead of print]
Joshi A, Tandon N, Patil VM, Noronha V, Gupta S, Bhattacharjee A, Prabhash K. J Cancer Res Ther.Agreement analysis between three different short geriatric screening scales in patients undergoing chemotherapy for solid tumors.2017 Oct-Dec;13(6):1023-1026. doi: 10.4103/0973-1482.179062.
Bajpai J, Ramaswamy A, Chandrasekharan A, Mishra S, Shet T, Gupta S, Badwe RA.Activation of phosphoinositide 3-kinase/Akt/mechanistic target of rapamycin pathway and response to everolimus in endocrine receptor-positive metastatic breast cancer - A retrospective pilot analysis and viewpoint.South Asian J Cancer. 2017 Jul-Sep;6(3):1
Bajpai J, Chandrasekharan A, Talreja V, Simha V, Chandrakanth MV, Rekhi B, Khurana S, Khan A, Vora T, Ghosh J, Banavali SD, Gupta S. Eur JOutcomes in non-metastatic treatment naive extremity osteosarcoma patients treated with a novel non-high dosemethotrexate-based, dose-dense combination chemotherapy regimen 'OGS-12'.Eur J Cancer. 2017 Nov;85:49-58. doi: 10.1016/j.ejca.2017.08.013. Epub 20
Godbole M, Chandrani P, Gardi N, Dhamne H, Patel K, Yadav N, Gupta S, Badwe R, Dutt A.miR-129-2 mediates down-regulation of progesterone receptor in response to progesterone in breast cancer cells.Cancer Biol Ther. 2017 Oct 3;18(10):801-805. doi: 10.1080/15384047.2017.1373216. Epub 2017 Sep 6.
- 2016Gulia S, Gupta S.
Reply to S. Rastogi et al.J Glob Oncol. 2016 Oct 12;3(2):184-185. doi: 10.1200/JGO.2016.006775. eCollection 2017 Apr. No abstract available.
Gulia S, Sengar M, Badwe R, Gupta S.National Cancer Control Programme in India: Proposal for Organization of Chemotherapy and Systemic Therapy Services. J Glob Oncol. 2016 Jun 22;3(3):271-274. doi: 10.1200/JGO.2015.001818. eCollection 2017 Jun.
Jyoti B, Bharat C, Ankita N, Munita B, Sudeep G.Pregnancy on tamoxifen: Case-report and review of literature.South Asian J Cancer. 2016 Oct-Dec;5(4):209-210. doi: 10.4103/2278-330X.195347. No abstract available.
Pantziarka P, Hutchinson L, André N, Benzekry S, Bertolini F, Bhattacharjee A, Chiplunkar S, Duda DG, Gota V, Gupta S, Joshi A, Kannan S, Kerbel R, Kieran M, Palazzo A, Parikh A, Pasquier E, Patil V, Prabhash K, Shaked Y, Sholler GS, Sterba J, Waxman DJ,Next generation metronomic chemotherapy-report from the Fifth Biennial International Metronomic and Anti-angiogenic Therapy Meeting, 6-8 May 2016, Mumbai.Ecancermedicalscience. 2016 Nov 2;10:689. eCollection 2016.
Coyle C, Cafferty FH, Rowley S, MacKenzie M, Berkman L, Gupta S, Pramesh CS, Gilbert D, Kynaston H, Cameron D, Wilson RH, Ring A, Langley RE; Add-Aspirin investigators.ADD-ASPIRIN: A phase III, double-blind, placebo controlled, randomised trial assessing the effects of aspirin on disease recurrence and survival after primary therapy in common non-metastatic solid tumours.Contemp Clin Trials. 2016 Nov;51:56-64. doi: 10.1
Nagrani R, Mhatre S, Rajaraman P, Soerjomataram I, Boffetta P, Gupta S, Parmar V, Badwe R, Dikshit R.Central obesity increases risk of breast cancer irrespective of menopausal and hormonal receptor status in women of South Asian Ethnicity.Eur J Cancer. 2016 Oct;66:153-61. doi: 10.1016/j.ejca.2016.07.022. Epub 2016 Aug 27.
Gulia S, Gupta S, Singh A.Intrathecal trastuzumab for leptomeningeal carcinomatosis in patients with human epidermal growth factor receptor 2 positive breast cancer. Indian J Med Paediatr Oncol. 2016 Jul-Sep;37(3):196-8. doi: 10.4103/0971- 5851.190354.
Bajpai J, Ramaswamy A, Gupta S, Ghosh J, Gulia S.Everolimus in heavily pretreated metastatic breast cancer: Is real world experience different?Indian J Cancer. 2016 Jul-Sep;53(3):464-467. doi: 10.4103/0019-509X.200657.
Bajpai J, Ramaswamy A, Gupta S, Ghosh J, Gulia S.Eribulin in heavily pretreated metastatic breast cancer: A tertiary care center experience from India.Indian J Cancer. 2016 Jul-Sep;53(3):460-463. doi: 10.4103/0019-509X.200653.
Gupta S.Breast cancer: Indian experience, data, and evidence.South Asian J Cancer. 2016 Jul-Sep;5(3):85-6. doi: 10.4103/2278-330X.187552.
Karpe A, Patil VM, Joshi A, Noronha V, Gupta S, Ramaswamy A, Sahu A, Doshi V, Gupta T, Rath S, Banavali S, Prabhash K.Weekly cisplatin (30-40 mg/m2) as radiosensitizer: Is it high or moderate emetic agent? Indian J Cancer. 2016 Jul-Sep;53(3):454-456. doi: 10.4103/0019-509X.200666.
Upadhyay P, Gardi N, Desai S, Sahoo B, Singh A, Togar T, Iyer P, Prasad R, Chandrani P, Gupta S, Dutt A.TMC-SNPdb: an Indian germline variant database derived from whole exome sequences. Database (Oxford). 2016 Jul 9;2016. pii: baw104. doi: 10.1093/database/baw104.
Upadhyay P, Nair S, Kaur E, Aich J, Dani P, Sethunath V, Gardi N, Chandrani P, Godbole M, Sonawane K, Prasad R, Kannan S, Agarwal B, Kane S, Gupta S, Dutt S, Dutt A.Notch pathway activation is essential for maintenance of stem-like cells in early tongue cancer.Oncotarget. 2016 Aug 2;7(31):50437-50449. doi: 10.18632/oncotarget.10419.
Pandey A, Abhay D, Sunny J, Vikas O, Vijay P, Rajeshri K, Netaji P, Sudeep G, Banavali SD.Outcomes of advanced epithelial ovarian cancer with integration of metronomic chemotherapy: An Indian rural cancer centre experience.South Asian J Cancer. 2016 Apr-Jun;5(2):59-62. doi: 10.4103/2278-330X.181627.
Kaur S, Kerkar RA, Maheshwari A, Shylasree TS, Gupta S, Deodhar K.Clinical characteristics with patterns of relapse and survival analysis of ovarian clear cell carcinoma.Indian J Cancer. 2016 Apr-Jun;53(2):288-291. doi: 10.4103/0019-509X.197719.
Paul D, Ostwal V, Bose S, Basu S, Gupta S.Personalized treatment approach to gastroenteropancreatic neuroendocrine tumors: a medical oncologist's perspective.Eur J Gastroenterol Hepatol. 2016 Sep;28(9):985-90. doi: 10.1097/MEG.0000000000000674. Review.
Pai T, Shet T, Desai S, Patil A, Nair N, Parmar V, Gupta S, Budrukkar A, Sarin R, Badwe R.Impact of Squamous Differentiation in Breast Carcinoma.Int J Surg Pathol. 2016 Sep;24(6):483-9. doi: 10.1177/1066896916642290. Epub 2016 Apr 12.
Bhat V, Gupta S, Kelkar R, Biswas S, Khattry N, Moiyadi A, Bhat P, Ambulkar R, Chavan P, Chiplunkar S, Kotekar A, Gupta T.Bacteriological profile and antibiotic susceptibility patterns of clinical isolates in a tertiary care cancer center.Indian J Med Paediatr Oncol. 2016 Jan-Mar;37(1):20-4. doi: 10.4103/0971- 5851.177010.
Kannan A, Wells RB, Sivakumar S, Komatsu S, Singh KP, Samten B, Philley JV, Sauter ER, Ikebe M, Idell S, Gupta S, Dasgupta S.Mitochondrial Reprogramming Regulates Breast Cancer Progression.Clin Cancer Res. 2016 Jul 1;22(13):3348-60. doi: 10.1158/1078-0432.CCR-15-2456. Epub 2016 Feb 17.
Gulia S, Khurana S, Shet T, Gupta S.Radiographically occult intrasinusoidal liver metastases leading to hepatic failure in a case of breast cancer.BMJ Case Rep. 2016 Feb 15;2016. pii: bcr2015214120. doi: 10.1136/bcr-2015- 214120.
Kelkar MG, Senthilkumar K, Jadhav S, Gupta S, Ahn BC, De A.Enhancement of human sodium iodide symporter gene therapy for breast cancer by HDAC inhibitor mediated transcriptional modulation.Sci Rep. 2016 Jan 18;6:19341. doi: 10.1038/srep19341.
Reichardt P, Demetri GD, Gelderblom H, Rutkowski P, Im SA, Gupta S, Kang YK, Schöffski P, Schuette J, Soulières D, Blay JY, Goldstein D, Fly K, Huang X, Corsaro M, Lechuga MJ, Martini JF, Heinrich MC.Correlation of KIT and PDGFRA mutational status with clinical benefit in patients with gastrointestinal stromal tumor treated with sunitinib in a worldwide treatment- use trial. BMC Cancer. 2016 Jan 15;16:22. doi: 10.1186/s12885-016-2051-5.
Murugan K, Ostwal V, Carvalho MD, D'souza A, Achrekar MS, Govindarajan S, Gupta S.Self-identification and management of hand-foot syndrome (HFS): effect of a structured teaching program on patients receiving capecitabine-based chemotherapy for colon cancer.Support Care Cancer. 2016 Jun;24(6):2575-81. doi: 10.1007/s00520-015-3061-6. Epu
Nagrani R, Mhatre S, Boffetta P, Rajaraman P, Badwe R, Gupta S, Romieu I, Parmar V, Dikshit R.Understanding rural-urban differences in risk factors for breast cancer in an Indian population.Cancer Causes Control. 2016 Feb;27(2):199-208. doi: 10.1007/s10552-015-0697-y. Epub 2015 Nov 20.
Dandekar M, Trivedi R, Irawati N, Prabhash K, Gupta S, Agarwal JP, D'Cruz AK.Barriers in conducting clinical trials in oncology in the developing world: A cross- sectional survey of oncologists.Indian J Cancer. 2016 Jan-Mar;53(1):174-7. doi: 10.4103/0019-509X.180865.
- 2015Chandrani P, Upadhyay P, Iyer P, Tanna M, Shetty M, Raghuram GV, Oak N, Singh A, Chaubal R, Ramteke M, Gupta S, Dutt A.
Integrated genomics approach to identify biologically relevant alterations in fewer samples. BMC Genomics. 2015 Nov 14;16:936. doi: 10.1186/s12864-015-2138-4.
Gulia S, Gota V, Kumar SD, Gupta S.Acute renal failure secondary to ingestion of alternative medication in a patient with breast cancer.J Cancer Res Ther. 2015 Oct-Dec;11(4):1006-8. doi: 10.4103/0973-1482.171362.
Badwe R, Gupta S, Nair N, Parmar V, Hawaldar R.Survival of patients with metastatic breast cancer with or without locoregional therapy - Authors' reply. Lancet Oncol. 2015 Dec;16(16):e587-8. doi: 10.1016/S1470-2045(15)00479-9.
Badwe R, Hawaldar R, Nair N, Kaushik R, Parmar V, Siddique S, Budrukkar A, Mittra I, Gupta S.Locoregional treatment versus no treatment of the primary tumour in metastatic breast cancer: an open-label randomised controlled trial.Lancet Oncol. 2015 Oct;16(13):1380-8. doi: 10.1016/S1470-2045(15)00135-7. Epub 2015 Sep 9.
Vaish R, Gupta S, D'Cruz AK.. Elective versus Therapeutic Neck Dissection in Oral Cancer – Authors’ Rep l N Engl J Med. 2015 Dec 17;373(25):2477. doi: 10.1056/NEJMc1511351.
D'Cruz AK, Vaish R, Kapre N, Dandekar M, Gupta S, Hawaldar R, Agarwal JP, Pantvaidya G, Chaukar D, Deshmukh A, Kane S, Arya S, Ghosh-Laskar S, Chaturvedi P, Pai P, Nair S, Nair D, Badwe RElective versus Therapeutic Neck Dissection in Node-Negative Oral Cancer.Head and Neck Disease Management Group. N Engl J Med. 2015 Aug 6;373(6):521-9. doi: 10.1056/NEJMoa1506007. Epub 2015 May 31.
Sahu A, Godbole S, Jain P, Ghosh J, Shrikhande S, Ramadwar M, Goyal M, Gulia S, Bajpai J, Kembhavi Y, Gupta S.Sunitinib in patients with imatinib-resistant gastrointestinal stromal tumor: A Indian J Cancer. 2015 Jul-Sep;52(3):320-3. doi: 10.4103/0019-509X.176747.single center experience study.
Dawood S, Haaland B, Albaracin C, Gupta S, Cortes J, Sim YY, Dent RA.Is the Proportion of Patients Diagnosed with Synchronous Stage IV Breast Cancer Who Survive More than Two Years Increasing over Time? Oncology. 2015;89(2):79-87. doi: 10.1159/000371746. Epub 2015 Apr 1.
Rekhi B, Parikh P, Deodhar KK, Menon S, Maheshwari A, Kerkar R, Gupta S.Squamous carcinoma coexistent with teratoma of ovary: a clinicopathological study of 12 cases diagnosed over a 10-year period at a tertiary cancer referral center. J Cancer Res Ther. 2015 Jan-Mar;11(1):211-5. doi: 10.4103/0973-1482.138083.
Kate S, Gulia S, Gupta S.Severe skin toxicity due to weekly paclitaxel administration.Indian J Med Paediatr Oncol. 2015 Jan-Mar;36(1):62. doi: 10.4103/0971- 5851.151795.
Budrukkar A, Gurram L, Upreti RR, Munshi A, Jalali R, Badwe R, Parmar V, Shet T, Gupta S, Wadasadawala T, Sarin R.Clinical outcomes of prospectively treated 140 women with early stage breast cancer using accelerated partial breast irradiation with 3 dimensional computerized tomography based brachytherapy.Radiother Oncol. 2015 Jun;115(3):349-54. doi: 10.1016/j.radonc.
Gupta S, Gulia S, Shetty N.Clinical trial ethics: one standard does not fit all.J Clin Oncol. 2015 Apr 20;33(12):1413-4. doi: 10.1200/JCO.2014.59.5371. Epub 2015 Feb 23.
- 2014Kaur E, Gupta S, Dutt S.
Clinical implications of MTA proteins in human cancer.Cancer Metastasis Rev. 2014 Dec;33(4):1017-24. doi: 10.1007/s10555-014-9527-z. Review.
Prabhash K, Bajpai J, Gokarn A, Arora B, Kurkure PA, Medhekar A, Kelkar R, Biswas S, Gupta S, Naronha V, Shetty N, Goyel G, Banavali SD.Comparison of isolates and antibiotic sensitivity pattern in pediatric and adult cancer patients; is it different ? Indian J Cancer. 2014 Oct-Dec;51(4):496-501. doi: 10.4103/0019-509X.175356.
Parikh PM, Gupta S, Dawood S, Rugo H, Bhattacharyya GS, Agarwal A, Chacko R, Sahoo TP, Babu G, Agarwal S, Munshi A, Goswami C, Smruti BK, Bondarde S, Desai C, Rajappa S, Somani N, Singh M, Nimmagadda R, Pavitran K, Mehta A, Parmar V, Desai S, Nair R, Dova. ICON 2013: practical consensus recommendations for hormone receptor-positive Her2-negative advanced or metastatic breast cancer.Indian J Cancer. 2014 Jan-Mar;51(1):73-9. doi: 10.4103/0019-509X.134650.
Kumar P, Bajpai J, Shetty N, Medekar A, Kurkure PA, Ghadyalpatil N, Gupta S, Noronha V, Kanujia A, Parikh P, Banavali SD.Management of febrile neutropenia in malignancy using the MASCC score and other factors: Feasibility and safety in routine clinical practice.Indian J Cancer. 2014 Oct-Dec;51(4):491-5. doi: 10.4103/0019-509X.175340.
Choughule A, Sharma R, Trivedi V, Thavamani A, Noronha V, Joshi A, Desai S, Chandrani P, Sundaram P, Utture S, Jambhekar N, Gupta S, Aich J, Prabhash K, Dutt A.Coexistence of KRAS mutation with mutant but not wild-type EGFR predicts response to tyrosine-kinase inhibitors in human lung cancer. Br J Cancer. 2014 Nov 25;111(11):2203-4. doi: 10.1038/bjc.2014.401. Epub 2014 Aug 12.
Rastogi S, Gulia S, Bajpai J, Ghosh J, Gupta S.Oligometastatic breast cancer: A mini review.Indian J Med Paediatr Oncol. 2014 Jul;35(3):203-6. doi: 10.4103/0971-5851.142035. Review.
Parikh PM, Prabhash K, Govind KB, Digumarti R, Pandit S, Banerjee I, Biyani R, Deshmukh A, Doval D, Bhattacharyya GS, Gupta S.80. Standard operating procedure for audio visual recording of informed consent: an initiative to facilitate regulatory compliance.Indian J Cancer. 2014 Apr-Jun;51(2):113-6. doi: 10.4103/0019-509X.138158.
Sirohi B, Gupta S, Raghunadharao D, Shrikhande SV.Clinical trials in India: At uncertain crossroads?Indian J Med Paediatr Oncol. 2014 Apr;35(2):133-5. doi: 10.4103/0971-5851.138947.
Cryptosporidiosis causing severe persistent diarrhea in a patient with multiple myeloma: A Case report and brief review of literature.Indian J Med Paediatr Oncol. 2014 Jan;35(1):93-5. doi: 10.4103/0971-5851.133731.
Gupta S.Progression-free or overall su rvival…revisi ted in B OLER O -2.Indian J Med Paediatr Oncol. 2014 Jan;35(1):1-2. doi: 10.4103/0971-5851.133701.
Gupta S, Kerkar RA, Dikshit R, Badwe RA.Authors' reply.South Asian J Cancer. 2014 Jan;3(1):94-5.
Dawood S, Lei X, Dent R, Gupta S, Sirohi B, Cortes J, Cristofanilli M, Buchholz T, Gonzalez-Angulo AM.Survival of women with inflammatory breast cancer: a large population-based study.Ann Oncol. 2014 Jun;25(6):1143-51. doi: 10.1093/annonc/mdu121. Epub 2014 Mar 24.
Shetty N, Gupta S.Eribulin drug review.South Asian J Cancer. 2014 Jan;3(1):57-9. doi: 10.4103/2278-330X.126527. Review.
Gulia S, Bajpai J, Gupta S, Maheshwari A, Deodhar K, Kerkar RA, Seth V, Rekhi B, Menon S.Outcome of gestational trophoblastic neoplasia: experience from a tertiary cancer centre in India.Clin Oncol (R Coll Radiol). 2014 Jan;26(1):39-44. doi: 10.1016/j.clon.2013.08.010. Epub 2013 Sep 17.